Option Care Health, Inc. (FRA:MM6A)
Germany · Delayed Price · Currency is EUR | Market Cap | 2.77B -41.8% |
| Revenue (ttm) | 4.92B +9.3% |
| Net Income | 178.83M -3.6% |
| EPS | 1.11 +2.4% |
| Shares Out | n/a |
| PE Ratio | 15.49 |
| Forward PE | 10.86 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 17.30 |
| Previous Close | 17.30 |
| Day's Range | 17.30 - 17.30 |
| 52-Week Range | 16.40 - 31.80 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 30, 2026 |
About Option Care Health
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arth... [Read more]
Financial Performance
In 2025, Option Care Health's revenue was $5.65 billion, an increase of 13.03% compared to the previous year's $5.00 billion. Earnings were $207.59 million, a decrease of -2.00%.
Financial numbers in USD Financial StatementsNews
Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
BANNOCKBURN, Ill., June 01, 2026 (GLOBE NEWSWIRE) -- Option Care Health is proud to announce it has been ranked No. 15 on the World's Most Impactful Companies 2026 list, a global recognition of organi...
Option Care Health Slides: Investor presentation
Option Care Health has posted slides in relation to its latest quarterly earnings report, which was published on May 27, 2026.
Option Care Health Transcript: AGM 2026
The meeting saw all director nominees elected and key proposals, including auditor ratification and executive compensation, approved by strong majorities. 2025 financials showed solid growth despite industry challenges, with ongoing initiatives to improve patient care and address recent performance issues.
Option Care Health Transcript: Bank of America Global Healthcare Conference 2026
The session highlighted a disruptive Q1 with a $175M revenue guidance reduction, but EBITDA guidance was maintained through cost controls and operational focus. Investments in technology, commercial resources, and share repurchases are prioritized, while the business remains confident in long-term growth and portfolio diversification.
Option Care Health Slides: FY 2026
Option Care Health has posted slides in relation to its FY 2026 quarterly earnings report, which was published on May 12, 2026.
Option Care Health price target lowered to $28 from $38 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Option Care Health (OPCH) to $28 from $38 and keeps an Overweight rating on the shares.
Option Care Health to Participate in the Bank of America Health Care Conference
BANNOCKBURN, Ill., May 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion servic...
Option Care Health price target lowered to $33 from $40 at JPMorgan
JPMorgan lowered the firm’s price target on Option Care Health (OPCH) to $33 from $40 and keeps an Overweight rating on the shares.
Option Care Health price target lowered to $23 from $37 at TD Cowen
TD Cowen lowered the firm’s price target on Option Care Health (OPCH) to $23 from $37 and keeps a Hold rating on the shares. The firm said the second half…
Option Care Health price target lowered to $30 from $40 at Stephens
Stephens lowered the firm’s price target on Option Care Health (OPCH) to $30 from $40 and keeps an Overweight rating on the shares. Adverse chronic infusion dynamics will weigh on…
Option Care Health downgraded to Neutral from Buy at BofA
BofA analyst Joanna Gajuk downgraded Option Care Health (OPCH) to Neutral from Buy with a $22 price target The firm, which worries that pressures from payors and increased competition could…
Option Care Health price target lowered to $39 from $45 at UBS
UBS lowered the firm’s price target on Option Care Health (OPCH) to $39 from $45 and keeps a Buy rating on the shares.
Option Care Health price target lowered to $32 from $42 at Barrington
Barrington lowered the firm’s price target on Option Care Health (OPCH) to $32 from $42 and keeps an Outperform rating on the shares. A “mixed bag” Q1 report and go-forward…
Option Care Health price target lowered to $30 from $40 at Truist
Truist lowered the firm’s price target on Option Care Health (OPCH) to $30 from $40 and keeps a Buy rating on the shares. The company reported mixed Q1 results, marked…
Option Care Health price target lowered to $26 from $38 at Deutsche Bank
Deutsche Bank analyst Pito Chickering lowered the firm’s price target on Option Care Health (OPCH) to $26 from $38 and keeps a Buy rating on the shares. Published first on…
Option Care Health price target lowered to $32 from $38 at Citizens
Citizens lowered the firm’s price target on Option Care Health (OPCH) to $32 from $38 and keeps an Outperform rating on the shares. The firm said there are “a lot…
Option Care Health falls -29.7%
Option Care Health (OPCH) is down -29.7%, or -$7.98 to $18.89.
Option Care Health falls -30.3%
Option Care Health (OPCH) is down -30.3%, or -$8.13 to $18.74.
Option Care Health, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Option Care Health, Inc. (NASDAQ: OPCH). The investigation focuses on Opt...
Option Care Health reports Q1 adjusted EPS 40c, consensus 37c
Reports Q1 revenue $1.35B, consensus $1.4B. “The first quarter reflected a mixed performance for our business, and we are not satisfied with our revenue growth momentum,” commented John C. Rademacher,...
Option Care Health Earnings Call Transcript: Q1 2026
Q1 2026 saw revenue up just over 1% year-over-year, with strong acute growth offset by chronic portfolio headwinds and a $55M gross profit impact from CID. Full-year guidance was revised downward for revenue but maintained for EBITDA and EPS, with decisive actions underway to rebuild growth.
Option Care Health Earnings release: Q1 2026
Option Care Health released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Option Care Health Slides: Q1 2026
Option Care Health has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Option Care Health Quarterly report: Q1 2026
Option Care Health has published its Q1 2026 quarterly earnings report on April 30, 2026.
Option Care Health backs FY26 adjusted EPS view $1.82-$1.92, consensus $1.86
Backs FY26 revenue view $5.68B-$5.78B, consensus $5.94B. Backs FY26 adjusted EBITDA view $480M-$505M.